[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100053551":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":25,"locations":31,"responsibleParty":75,"collaborators":77,"id":81,"slug":18,"hasResults":82,"nctId":83,"briefTitle":84,"officialTitle":85,"acronym":86,"eligibilityCriteria":87,"healthyVolunteers":82,"sex":88,"minAge":89,"maxAge":18,"enrollmentInfo":90,"targetDuration":18,"studyType":93,"phases":94,"briefSummary":96,"conditions":97,"keywords":99,"overallStatus":34,"whyStopped":18,"lastUpdateSubmitDate":101,"lastUpdatePostDateStruct":102,"startDateStruct":105,"completionDateStruct":107,"leadSponsor":109,"locationsCount":110},{"fullName":5,"class":6},"Massachusetts General Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"THRIVE Digital Health App","ACTIVE_COMPARATOR","Patients assigned to the intervention will be provided a study-issued tablet computer from which they will access the THRIVE digital health app. Study staff will give intervention patients a comprehensive tutorial and detailed instructions regarding how to use the app. Tutorial sessions may be conducted in person during a clinic appointment, via telephone, and\u002For via Zoom videoconferencing. Participants will complete the intervention modules at their desired pace over approximately 10 weeks.",[13],"Behavioral: Digital Health App",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual Care","NO_INTERVENTION","Patients assigned to the usual care group will not receive the digital app but rather standard oncology care.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"BEHAVIORAL","Digital Health App","access to a digital health app",[9],[26],{"name":27,"role":28,"phone":29,"phoneExt":18,"email":30},"Jennifer Temel","CONTACT","6177244000","jtemel@partners.org",[32,49,59],{"facility":33,"status":34,"city":35,"state":36,"zip":37,"country":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"University of California Los Angeles","RECRUITING","Los Angeles","California","90024","United States",{"type":40,"coordinates":41},"Point",[42,43],-118.24368,34.05223,{"lat":43,"lon":42},[46],{"name":47,"role":28,"phone":18,"phoneExt":18,"email":48},"Anne Walling","AWalling@mednet.ucla.edu",{"facility":50,"status":51,"city":35,"state":36,"zip":52,"country":38,"cosmosGeoPoint":53,"geoPoint":55,"contacts":56},"Veteran Affairs Greater Los Angeles Health Care","NOT_YET_RECRUITING","90073",{"type":40,"coordinates":54},[42,43],{"lat":43,"lon":42},[57],{"name":47,"role":28,"phone":18,"phoneExt":18,"email":58},"anne.walling@va.gov",{"facility":5,"status":34,"city":60,"state":61,"zip":62,"country":38,"cosmosGeoPoint":63,"geoPoint":67,"contacts":68},"Boston","Massachusetts","02114",{"type":40,"coordinates":64},[65,66],-71.05977,42.35843,{"lat":66,"lon":65},[69,73],{"name":70,"role":28,"phone":71,"phoneExt":18,"email":72},"Jennifer Temel, MD","617-724-4000","JTEMEL@mgh.harvard.edu",{"name":70,"role":74,"phone":18,"phoneExt":18,"email":18},"PRINCIPAL_INVESTIGATOR",{"type":74,"investigatorFullName":70,"investigatorTitle":76,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Principal Investigator",[78],{"name":79,"class":80},"United States Department of Defense","FED","100053551",false,"NCT06427954","Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer","Randomized Trial of Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer","THRIVE","Inclusion Criteria:\n\n* Adults (greater than or equal to 18 years)\n* Diagnosed with advanced non-small cell lung cancer (NSCLC) that is not being treated with curative intent or extensive stage small cell lung cancer (SCLC) within the past 12 weeks.\n* Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) = 0-2 (i.e., fully active to at least ambulatory and up and about more than 50% of waking hours).\n* Sufficient English proficiency to utilize THRIVE in English (Note: patients can complete outcome measures in Spanish if preferred).\n\nExclusion Criteria:\n\n* Significant uncontrolled psychiatric disorder (e.g., psychotic disorder, bipolar disorder, major depression) or other co-morbid disease (e.g., dementia, cognitive impairment), which the treating oncology clinician reports would prohibit the ability to participate in study procedures.","ALL","18 Years",{"count":91,"type":92},250,"ESTIMATED","INTERVENTIONAL",[95],"NA","Multi-site randomized trial of the THRIVE digital health application versus usual care to evaluate the effect of THRIVE on quality of life (QOL), physical and psychological symptoms, coping, and self-efficacy in 250 patients with newly diagnosed advanced lung cancer.",[98],"Lung Cancer",[100],"Quality of life","2026-07-09",{"date":103,"type":104},"2026-07-13","ACTUAL",{"date":106,"type":104},"2024-08-06",{"date":108,"type":92},"2027-12",{"name":5,"class":6},3]